Nicola Sturgeon opens HCi Viocare’s new Glasgow R&D centre and P&O clinic | HCi Viocare | Prosthetics and orthotics clinic in Scotland


Sturgeon HCI Viocare Visit

A cutting edge health tech research centre, set up in Glasgow by bioengineering company HCi Viocare to develop and commercialise smart sensors that help prevent diabetic foot ulcers and athletic injuries, is being officially opened today by First Minister and local MSP Nicola Sturgeon.

The US OTC markets-listed company’s new research and development centre was opened together with its first prosthetics and orthotics clinic. The company has already brought substantial inward investment into the city’s Govan area, having so far created five scientific and professional jobs at its dual facility, with more to come.

Nicola Sturgeon said “I’m delighted to open this new facility and very much welcome HCi Viocare’s investment in Govan.  I congratulate everyone involved in establishing the centre and look forward to seeing how this innovative technology progresses.”

HCi Viocare’s co-founder and Chief Technology Officer Christos Kapatos commented, “Today’s opening is an important landmark for HCi Viocare. As well as actively seeking partners to commercialise our smart sensors and other technologies internationally, we aim to extend prosthetics and orthotics clinics across Mediterranean Europe based on the model being established by our new Glasgow clinic.”

The company’s near-market innovations include patent-pending low cost, smart sensing systems, incorporated into insoles for monitoring and preventing diabetic foot ulcers, as well as for monitoring athletic performance and preventing common running injuries. Multiple adaptations of the technology exist in health and sports sectors, including smart mattresses for preventing pressure sores.

HCi Viocare’s prosthetics and orthotics clinic is the only independent provider in Scotland. As well as seeing clients from Scotland, the north of England and beyond, it will act as a centre of reference and training for the company’s future clinics in European and Middle Eastern countries, where prosthetics and orthotics services are generally less developed than in the UK.

Dr Kapatos added, “Scotland is renowned for its innovation, highly skilled workforce and commitment to commercialisation. We value having our technology hub and first clinic here in Glasgow. We expect to create further high calibre jobs, recruiting from my alma mater the University of Strathclyde where possible, contributing to our company’s success as well as to Scotland’s economy and international reputation.”